SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

TGV Sraac gets nod to make further investment of Rs 10 crore in BBPL

20 May 2022 Evaluate

TGV Sraac has received an approval for making further investment of upto Rs 10 crore in Brilliant Bio Pharma (BBPL). The company intends to enter into the field of pharma in future for forward integration and value addition. By partnering with the already established BBPL will help the company to understand and make a step to focus on the pharma for future. The Board of Directors in their meeting held on May 19, 2022 has given approval to the same.

TGV Sraac (Formerly Known as Sree Rayalaseema Alkalies and Allied Chemicals) is engaged in the Business of leading producer of Chlor-Alkali products, Chloromethane and also manufactures Castor Derivatives and Fatty Acids.

TGV SRACC Share Price

108.46 -4.71 (-4.16%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3653.10
Tata Chemicals 704.05
SRF 2464.40
Pidilite Inds. 1390.15
Deepak Nitrite 1537.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×